News for Mallinckrodt plc (MNKKQ)

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of

Endo Inc's diverse portfolio and recent strategic moves position it for potential growth amidst industry challenges.Financial restructuring and a planned merge

PR NewswireMALVERN, Pa., May 7, 2025 XIAFLEX® revenues grew 7% compared to first-quarter 2024The Company reaffirms 2025 revenue guidance of $1,775 to $1,8

NEW YORK, May 03, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of

Mallinckrodt to present five clinical studies on TERLIVAZ® (terlipressin) at Digestive Disease Week 2025. Research focuses on treating hepatorenal synd

Mallinckrodt plc (MNK) to announce Q1 2025 earnings on May 6, 2025. Investor conference call scheduled at 8:30 a.m. ET alongside the earnings release.

Transaction Overview On March 13, 2025, Silver Point Capital L.P. (Trades, Portfolio) executed a significant transaction by acquiring 1,692,330 shares of Mallin

On March 13, 2025, Hein Park Capital Management LP (Trades, Portfolio) made a notable move by acquiring 1,914,673 shares of Mallinckrodt PLC (MCKPF). This trans

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

Endo International plc (OTC:ENDPQ) Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President of...

PR NewswireMALVERN, Pa., March 13, 2025 Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic prioritiesX

PR NewswireDUBLIN and MALVERN, Pa., March 13, 2025 Transaction Brings Together Two Highly Complementary Businesses to Broaden Patient Access and Develop Ne

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction

On November 19, 2024, Bracebridge Capital, LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 355,449 shares of Mallinckrodt PLC. This acqui

Mallinckrodt Presents Data on TERLIVAZ ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024

Overview of Hudson Bay's Recent Transaction On May 31, 2024, Hudson Bay Capital Management LP (Trades, Portfolio) made a significant move in the pharmaceutical

Mallinckrodt Announces an Expanded Rollout of the INOmax ® EVOLVE™ DS Delivery System in U.S. Hospitals

Opioid overdose menace causing ill effects on brain functioning and pushing demand for supportive treatment options....

Structure Therapeutics Appoints Angus C. Russell to Board of Directors